publication date: Jul. 6, 2018

Funding Opportunities DOD Peer Reviewed Cancer Research Program opportunities

The FY18 Defense Appropriations Act provides $80 million to the Department of Defense Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research. 

FY18 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov.

Congressionally Directed Topic Areas: To be considered for funding, applications for the FY18 PRCRP must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney, or ovarian cancer will not be accepted.

The FY18 PRCRP Topic Areas are:

Adrenal cancers

Bladder cancer

Blood cancers

Brain cancer

Immunotherapy

Listeria-based regimens for cancer

Liver cancer

Lymphoma

Myeloma

Neuroblastoma

Pancreatic cancer

The FY18 PRCRP Military Relevance Focus Areas are listed below:

To address the cancer health needs of both deployed and non-deployed personnel, their dependents, retirees, and Veterans, the FY18 PRCRP seeks to support studies that are responsive to at least one of Military Relevance Focus Areas listed below:

Militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, environmental carcinogens, and stress)

Gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may impact mission … Continue reading DOD Peer Reviewed Cancer Research Program opportunities

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.